- Home
- About ASF
- What is Autism?
- How Common is Autism?
- Signs and Symptoms of Autism
- Autism Diagnosis
- Following a Diagnosis
- Treatment Options
- Beware of Non-Evidence-Based Treatments
- Statement on Use of Medical Marijuana for People with Autism
- Autism and Vaccines
- Autism Science
- Quick Facts About Autism
- What We Fund
- Get Involved
- Resources
- COVID-19 Resources
- Day of Learning
- Contact Us
First Prospective Study on the Effect of Shank3 Deficiency on Phelan-McDermid Syndrome
Published June 11, 2013
in Molecular Autism
ASF Scientific Advisory Board Member, Joe Buxbaum, directed the first prospective study on the effects of Shank3 deficiency on a subtype of autism called 22q13 Deletion Syndrome, also known as Phelan-McDermid Syndrome.
http://www.molecularautism.com/content/pdf/2040-2392-4-18.pdf
Filed under: Autism News, Autism Research, Autism Science, featured, Genetics, Shank3